Prevalence and trend of allergen sensitization in patients with nummular (discoid) eczema referred for patch testing: North American Contact Dermatitis Group data, 2001-2016.


Journal

Contact dermatitis
ISSN: 1600-0536
Titre abrégé: Contact Dermatitis
Pays: England
ID NLM: 7604950

Informations de publication

Date de publication:
Jul 2021
Historique:
revised: 09 02 2021
received: 18 01 2021
accepted: 10 02 2021
pubmed: 27 2 2021
medline: 26 11 2021
entrez: 26 2 2021
Statut: ppublish

Résumé

Few studies have examined the relationship between nummular (discoid) eczema (NE) and allergic contact dermatitis (ACD). To examine trends, associations, and clinical relevance of ACD in patients with NE who were referred for patch testing. Retrospective analysis of 38 723 patients from the North American Contact Dermatitis Group. Overall, 748 patients (1.9%) were diagnosed with NE; 23.9% had a concomitant diagnosis of ACD. The prevalence of NE fluctuated over time between 2001 and 2016, with no overall change in prevalence in diagnosed NE. In multivariable logistic regression models, NE increased steadily with age and was associated with male sex and Asian and other race/ethnicity, and inversely associated with a history of atopic dermatitis (AD) and hay fever. Patients with NE had lower proportions of one or more positive allergic reactions and lower odds of a positive reaction in multiple individual allergens. The most commonly relevant allergens in patients with NE were formaldehyde 2.0% aq., methylisothiazolinone, quaternium 15, fragrance mix I, and propylene glycol. NE is a heterogeneous disorder with distinct subsets of lesional distributions and a profile of relevant allergens, especially formaldehyde and formaldehyde releasers. Nearly one in four patients with NE had ACD, supporting the role of patch testing in patients with NE.

Sections du résumé

BACKGROUND BACKGROUND
Few studies have examined the relationship between nummular (discoid) eczema (NE) and allergic contact dermatitis (ACD).
OBJECTIVE OBJECTIVE
To examine trends, associations, and clinical relevance of ACD in patients with NE who were referred for patch testing.
METHODS METHODS
Retrospective analysis of 38 723 patients from the North American Contact Dermatitis Group.
RESULTS RESULTS
Overall, 748 patients (1.9%) were diagnosed with NE; 23.9% had a concomitant diagnosis of ACD. The prevalence of NE fluctuated over time between 2001 and 2016, with no overall change in prevalence in diagnosed NE. In multivariable logistic regression models, NE increased steadily with age and was associated with male sex and Asian and other race/ethnicity, and inversely associated with a history of atopic dermatitis (AD) and hay fever. Patients with NE had lower proportions of one or more positive allergic reactions and lower odds of a positive reaction in multiple individual allergens. The most commonly relevant allergens in patients with NE were formaldehyde 2.0% aq., methylisothiazolinone, quaternium 15, fragrance mix I, and propylene glycol.
CONCLUSION CONCLUSIONS
NE is a heterogeneous disorder with distinct subsets of lesional distributions and a profile of relevant allergens, especially formaldehyde and formaldehyde releasers. Nearly one in four patients with NE had ACD, supporting the role of patch testing in patients with NE.

Identifiants

pubmed: 33634511
doi: 10.1111/cod.13824
doi:

Substances chimiques

Allergens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

46-57

Informations de copyright

© 2021 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd.

Références

Kulthanan K, Samutrapong P, Jiamton S, Tuchinda P. Adult-onset atopic dermatitis: a cross-sectional study of natural history and clinical manifestation. Asian Pac J Allergy Immunol. 2007;25(4):207-214.
Silverberg JI. Adult-onset atopic dermatitis. J Allergy Clin Immunol Pract. 2019;7(1):28-33.
Silverberg JI, Vakharia PP, Chopra R, et al. Phenotypical differences of childhood- and adult-onset atopic dermatitis. J Allergy Clin Immunol Pract. 2018;6(4):1306-1312.
Vakharia PP, Silverberg JI. Adult-onset atopic dermatitis: characteristics and management. Am J Clin Dermatol. 2019;20(6):771-779.
Yew YW, Thyssen JP, Silverberg JI. A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics. J Am Acad Dermatol. 2019;80(2):390-401.
Owen JL, Vakharia PP, Silverberg JI. The role and diagnosis of allergic contact dermatitis in patients with atopic dermatitis. Am J Clin Dermatol. 2018;19(3):293-302.
Aoyama H, Tanaka M, Hara M, Tabata N, Tagami H. Nummular eczema: an addition of senile xerosis and unique cutaneous reactivities to environmental aeroallergens. Dermatology. 1999;199(2):135-139.
Bonamonte D, Foti C, Vestita M, Ranieri LD, Angelini G. Nummular eczema and contact allergy: a retrospective study. Dermatitis. 2012;23(4):153-157.
Silverberg JI. Chapter 23: nummular eczema, lichen simplex Chrosnicus, and Prurigo Nodularis. In: Kang S, Fitzpatrick TB, Kang S, eds. Fitzpatrick's Dermatology. 9th ed. New York, NY: McGraw-Hill Education:2019.
Jiamton S, Tangjaturonrusamee C, Kulthanan K. Clinical features and aggravating factors in nummular eczema in Thais. Asian Pac J Allergy Immunol. 2013;31(1):36-42.
Kim WJ, Ko HC, Kim MB, Kim DW, Kim JM, Kim BS. Features of Staphylococcus aureus colonization in patients with nummular eczema. Br J Dermatol. 2013;168(3):658-660.
Higgins EM, Du Vivier AW. Cutaneous disease and alcohol misuse. Br Med Bull. 1994;50(1):85-98.
Krupa Shankar DS, Shrestha S. Relevance of patch testing in patients with nummular dermatitis. Indian J Dermatol Venereol Leprol. 2005;71(6):406-408.
Leung AKC, Lam JM, Leong KF, Leung AM, Wong AHC, Hon KL. Nummular eczema: an updated review. Recent Pat Inflamm Allergy Drug Discov. 2020;14(2):146-155.
Pratt MD, Belsito DV, Deleo VA, et al. North American contact dermatitis group patch-test results, 2001-2002 study period. Dermatitis. 2004;15(4):176-183.
Dekoven JG, Warshaw EM, Zug KA, et al. North American contact dermatitis group patch test results: 2015-2016. Dermatitis. 2018;29(6):297-309.
Dekoven JG, Warshaw EM, Belsito DV, et al. North American contact dermatitis group patch test results 2013-2014. Dermatitis. 2017;28(1):33-46.
Warshaw EM, Aschenbeck KA, Dekoven JG, et al. Epidemiology of pediatric nickel sensitivity: retrospective review of north American contact dermatitis group (NACDG) data 1994-2014. J Am Acad Dermatol. 2018;79(3):664-671.
Maouad M, Fleischer AB Jr, Sherertz EF, Feldman SR. Significance-prevalence index number: a reinterpretation and enhancement of data from the north American contact dermatitis group. J Am Acad Dermatol. 1999;41(4):573-576.
Silverberg JI, Warshaw EM, Atwater AR, et al. Hand dermatitis in adults referred for patch testing: analysis of north American contact dermatitis group data, 2000-2016. J Am Acad Dermatol. 2020; In Press. https://doi.org/10.1016/j.jaad.2020.11.054. Online ahead of print.
Khurana S, Jain VK, Aggarwal K, Gupta S. Patch testing in discoid eczema. J Dermatol. 2002;29(12):763-767.
Kang IJ, Shin MK, Haw CR. Patch testing in nummular eczema: comparison of patch test results between nummular eczema and atopic dermatitis. Korean J Dermatol. 2007;45(9):871-876.
Lundov MD, Johansen JD, Carlsen BC, Engkilde K, Menné T, Thyssen JP. Formaldehyde exposure and patterns of concomitant contact allergy to formaldehyde and formaldehyde-releasers. Contact Dermatitis. 2010;63(1):31-36.
Carew B, Muir J. Patch testing for allergic contact dermatitis to cigarettes: smoked/unsmoked components and formaldehyde factors. Australas J Dermatol. 2014;55(3):225-226.
Burkemper NM. Contact dermatitis, patch testing, and allergen avoidance. Mo Med. 2015;112(4):296-300.
Kuritzky LA, Pratt M. Systemic allergic contact dermatitis after formaldehyde-containing influenza vaccination. J Cutan Med Surg. 2015;19(5):504-506.
Schnuch A, Schubert S, Lessmann H, Geier J. The methylisothiazolinone epidemic goes along with changing patients' characteristics - after cosmetics, industrial applications are the focus. Contact Dermatitis. 2020;82(2):87-93.
Uter W, Geier J, Bauer A, Schnuch A. Risk factors associated with methylisothiazolinone contact sensitization. Contact Dermatitis. 2013;69(4):231-238.
Geier J, Lessmann H, Schnuch A, Uter W. Recent increase in allergic reactions to methylchloroisothiazolinone/methylisothiazolinone: is methylisothiazolinone the culprit? Contact Dermatitis. 2012;67(6):334-341.
Johansen JD. Fragrance contact allergy: a clinical review. Am J Clin Dermatol. 2003;4(11):789-798.
Scheinman PL. Allergic contact dermatitis to fragrance: a review. Am J Contact Dermat. 1996;7(2):65-76.
Mcgowan MA, Scheman A, Jacob SE. Propylene glycol in contact dermatitis: a systematic review. Dermatitis. 2018;29(1):6-12.
Lowther A, Mccormick T, Nedorost S. Systemic contact dermatitis from propylene glycol. Dermatitis. 2008;19(2):105-108.
Mai W, Liu X, Su G, Zhou W, Wen Z, Lu D. Elevation of circulating Th17/Th22 cells exposed to low-level formaldehyde and its relevance to formaldehyde-induced occupational allergic contact dermatitis. J Occup Environ Med. 2017;59(9):817-821.
Boehner A, Lauffer F, Biedermann T, Eyerich K. 1010 nummular eczema is a distinct clinical entity with overlapping features of both, psoriasis and atopic eczema. J Invest Dermatol. 2018;138(5):S171.
Fischer T, Maibach HI. Easier patch testing with TRUE test. J Am Acad Dermatol. 1989;20(3):447-453.
Martínez-Blanco J, García-González V, González-García J, Suárez-Castañón C. Nummular dermatitis: report of two cases in children. Arch Argent Pediatr. 2016;114(4):e241-e244.
Hellgren L, Mobacken H. Nummular eczema-clinical and statistical data. Acta Derm Venereol. 1969;49(2):189-196.
Carr RD, Berke M, Becker SW. Incidence of atopy in the general population. Arch Dermatol. 1964;89(1):27-32.
Krueger GG, Kahn G, Weston WL, Mandel MJ. IgE levels in nummular eczema and ichthyosis. Arch Dermatol. 1973;107(1):56-58.

Auteurs

Jonathan I Silverberg (JI)

Department of Dermatology, George Washington University School of Medicine, Washington, District of Columbia, USA.

Alexander Hou (A)

Department of Dermatology, Feinberg School of Medicine, Northwestern University, Evanston, Illinois, USA.

Erin M Warshaw (EM)

Department of Dermatology, Park Nicollet Health Services, Minneapolis, Minnesota, USA.
Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA.
Department of Dermatology, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota, USA.

Howard I Maibach (HI)

Department of Dermatology, University of California San Francisco, San Francisco, California, USA.

Donald V Belsito (DV)

Department of Dermatology, Columbia University, New York, New York, USA.

Joel G DeKoven (JG)

Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Kathryn A Zug (KA)

Department of Dermatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.

James S Taylor (JS)

Department of Dermatology, Cleveland Clinic, Cleveland, Ohio, USA.

Denis Sasseville (D)

Division of Dermatology, Montreal General Hospital, McGill University, Montreal, Quebec, Canada.

Anthony F Fransway (AF)

Associates in Dermatology, Fort Myers, Florida, USA.

Vincent A DeLeo (VA)

Department of Dermatology, Keck School of Medicine, Los Angeles, California, USA.

Melanie D Pratt (MD)

Division of Dermatology, University of Ottawa, Ottawa, Ontario, Canada.

Margo J Reeder (MJ)

Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Amber R Atwater (AR)

Department of Dermatology, Duke University Medical Center, Durham, North Carolina, USA.

Joseph F Fowler (JF)

Division of Dermatology, University of Louisville, Louisville, Kentucky, USA.

Matthew J Zirwas (MJ)

Department of Dermatology, Ohio State University, Columbus, Ohio, USA.

James G Marks (JG)

Department of Dermatology, Pennsylvania State University, State College, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH